Industry Analysis
Musk's exclusion of TSMC from Terafab's operational stack is the execution phase of America's single-node de-risking doctrine for strategic compute.
Technically, Terafab cannot replicate TSMC's 30-year yield curve. The probable path: a Chiplet-plus-advanced-packaging architecture distributing 3nm-class performance across mature-node dies. This shifts equipment TAM toward BESI and ASMPT (hybrid bonding, TSV) and bifurcates ASML's High-NA EUV demand curve.
Cost-wise, Intel's Ohio plant—three years to first wafer, $20B+ spent—sets the floor. Terafab's per-fab Capex likely lands at $15-25B, with a brutal 18-month depreciation trough before yield stabilizes.
Competitively, TSMC loses more than a customer: the narrative that US strategic silicon must transit Taiwan, China is structurally broken. Samsung and Intel Foundry will aggressively court Terafab's PDK-qualification and design-validation contracts.
12-24 month outlook: the foundry landscape shifts from one-dominant-several-strong to bipolar-plus-fragmented. US domestic advanced-node share climbs from under 5% toward 15-20%. Yet 2nm GAA and 1.4nm CFET remain TSMC's structural moat through 2027. Terafab's value is redundancy, not supremacy.
This page displays AI-generated summaries and metadata for research purposes. Original content belongs to the respective publishers.